All News
All news
-
News TCR2 bets on lead candidate with new cell therapy manufacturing facility
The US facility in Rockville is expected to accelerate the company’s commercial-scale manufacturing timelines of gavo-cel -
News Lonza to support Pionyr Immunotherapeutics' oncology drug development
The CDMO will provide cell line development, process development, drug substance and drug product manufacturing for Pionyr’s monoclonal antibody candidate -
News KD Pharma expands CDMO capabilities via asset acquisition
The former Rohner's manufacturing assets will enable omega-3 heavyweight to manufacture difficult, multi-step pharmaceutical intermediates and APIs -
News GSK to manufacture 60 million doses of Novavax vaccine for the UK
Pharma company will provide fill and finish manufacturing capacity at its Barnard Castle facility as early as the beginning of May 2021 -
News CPHI Webinar Series: Latest Approaches for Large Volume Drug Delivery
Innovation in the design and development of large volume drug delivery devices can solve the challenge of accommodating the increasing trend towards patient self-administration and home care while at the same time ensuring that drugs that require intra... -
News Nutrition additive supply chains 'nervous' as Suez blockage continues
Some seaborne deliveries are being rerouted or switched to air transportation as efforts to re-float stricken Ever Given container vessel move into fourth day -
News Origin Pharma Packaging opens new UK warehouse in significant capacity expansion
New site includes warehouse maagement system which packaging firm claims will increase picking accuracy and efficiency -
News The Evolution of Pharma R&D Models: Watch Webinar Now
While research and development (R&D) in the pharma sector has traditionally been largely constrained to in-house activity, companies are now much more open to the idea of outsourcing their innovation to remain competitive amid spiralling costs of drug ... -
News CURE Pharmaceutical gains DEA go-ahead to research psychedelics compounds
Company will use extension of Schedule I licence to start development of psychedelics-based pipeline to treat mental health disorders -
News China's Raybow Pharmaceuticals invests $15.8 million to expand US facility
The company will triple its capacity and workforce at its North Carolina site to increase its global capabilities and reach -
News The PSCI supports the Musi River Revitalization Initiative, Hyderabad India
A quarterly series of blog posts about responsible supply chain management from the PSCI Chair, Manjit Singh -
News Pharmapack Podcast Series: Patient-Centric Packaging Design & Innovation - Part Two
Partnering with one of northern Europe’s oldest academic universities, Lund University in Sweden, Pharmapack has launched this three-part podcast series, delivering the latest insights on medication packaging innovation and the gathering momentum... -
News Catalent signs ODT technology development agreement with Cybin
The CDMO's Zydis technology will help the Canadian biotech to develop fast-acting, shorter-duration formulations of its potential therapy for treatment-resistant psychiatric disorders -
News Fujifilm names North Carolina as location for $2 billion large-scale cell manufacturing site
CDMO subsidiary Fujifilm Diosynth Biotechnologies will operate the site which is expected to be operational in 2025 -
News Pharma Explained: Principles of Continuous Manufacturing
Pharma’s uptake of continuous manufacturing is slowly gaining traction as the technology does hold some key advantages over traditional batch manufacturing, such as the potential to realise cost savings and the promise of lower yield loss. -
News Pharma importers forced to reorganise supply chains due to Brexit complications, says medicines trade expert
EU/UK trade deal fell way short of UK’s initial expectations for medicinal products ahead of negotiations, says Peter Gough at NSF International -
News Pfizer to sell Chinese biologics manufacturing facility to WuXi
Multinational makes ‘difficult decision’ to halt presence in Chinese biosimilars market five years after $350 million investment -
News Wuxi Vaccines' Ireland site still on course for 2022 despite COVID challenges
Despite COVID-related challenges and supply chain issues, the CDMO's $240 million new facility is on target to open next year -
News Artificial intelligence a no-brainer for drug discovery
AI is helping pharma find the drug candidates with the greatest chance of success, according to experts who say therapeutic efficacy and cost reduction are the key dynamics -
News PCI Pharma Services expands Berlin cold chain clinical supply storage capabilities
The move ensures the service provider has the capacity to meet the needs of an evolving clinical market -
News Growing drug delivery CDMO Kindeva expands UK operations
US-headquartered company Kindeva seals deal for an R&D facility at Loughborough’s life sciences hub -
News Excipients – an industry adapting to change
Excipients are a crucial component of the pharmaceutical product formulation, and the industry is constantly having to adapt to changes in demand and technology innovations -
News Adaptive clinical trial success calls for flexible approach
Adaptive clinical trials have accelerated COVID-19 vaccine development and could make drug R&D more efficient but running such studies is complex and challenging and sponsors need to prepare, say experts -
News European countries suspend use of AstraZeneca COVID-19 vaccine as regulators investigate blood clot reports
Regulators stress temporary halt is precautionary measure and that there is currently no evidence linking the shot to adverse events -
News Growth opportunities abound for auto-injectors amid patient-centric healthcare transition, experts tell CPHI webinar
Tremendous growth opportunities exist for auto-injectors as their value is increasingly being recognised across several therapy areas, experts have told a recent CPHI webinar, sponsored by Stevanato Group. -
News Pharma Explained: Active Pharmaceutical Ingredients
What are APIs? As the name suggests, Active Pharmaceutical Ingredients (APIs) are the heart of any dosage form, whether they are oral, injectable or inhaled, and are absolutely essential to the development of a formulated product. -
News ANI Pharmaceuticals expands CDMO business through Novitium acquisition
The purchase will allow the company to add nine new customers to its growing CDMO business and 27 manufacturing suites -
News Special Podcast: CPHI Outlook Roundtable - Listen Now
In this special roundtable podcast exploring potential opportunities in a post-vaccinated world, we are joined by a panel of three world class experts – Bikash Chatterjee, CEO of Pharmatech Associates; Parrish Galliher, Managing Director, Bi... -
News Clinical Development Success Rates and Contributing Factors 2011-2020: New Report from Informa Pharma Intelligence
Biologic products advance through clinical development with a higher success rate than traditional small molecules, this new analysis of clinical development success from Informa Pharma Intelligence, the Biotechnology Industry Organization and the... -
News Inhalation specialist Vectura invests to expand manufacturing capabilities
The enhancements will include installing the lever-operated multi-dose inhaler device used in Hikma’s generic Advair product, which the FDA recently approved -
News CPHI post-pandemic report forecasts explosion of contract services growth
During the next 12 months, demand for early-stage contract projects could quickly exceed supply -
News Lonza to develop and manufacture Ixogen's oncolytic virus
PsiVac has generated compelling efficacy data in killing a broad range of tumour cells, including head and neck, bladder, liver, pancreatic and ovarian -
News CPHI Podcast Series: Decentralised Clinical Trial Design - Collecting Real World Data in a Remote Setting
In this podcast interview with Fabien Du Fraisse and Deepu Joseph at Quanticate, we delve into the trend of decentralising clinical trials -
News Merck agrees to support Johnson & Johnson in vaccine manufacturing deal
Funding from BARDA helps the company to adapt and make available a number of existing manufacturing facilities for the production of SARS-CoV-2 vaccines and medicines -
News WuXi AppTec completes $135 million acquisition of Oxgene
The addition further strengthens WuXi's cell and gene therapy service offerings for global customers and will be Wuxi ATU's first facility in Europe -
News WEBINAR: Driving Digital Transformation in Pharma – Watch Now!
Watch this recent webinar which looks at how pharma is partnering with digital tech companies in order to find market-based solutions to current issues and take advantage of the larger volumes of data now available -
News Pharmaron pays $118.7 million for AbbVie UK biomanufacturing site
This transaction complements Pharmaron’s recent acquisition of Absorption Systems in the US for building an integrated cell and gene therapy services platform -
News Pharma Explained: What is Quality Assurance?
Need clarity on determining your QA from your QbD and your cGMPs? You’re not alone! In our new Pharma Explained series from CPHI, we bring you clear cut definitions from industry experts on a myriad of Pharma Terms, delivered in bitesize video presenta... -
News COVID and complexity drive pharma supply chain adoption of digital distribution
The ongoing global pandemic and growing complexity mean digital technologies are fast becoming the only effective way of managing drug supply chains and logistics -
News Catalent takes double action to boost cell and gene therapy services
The company acquires a pDNA CDMO and launches pDNA development and manufacturing services at its Rockville, Maryland facility -
News Pharma Explained: What does 3D Printing actually mean for Pharmaceuticals?
Need clarity on determining your QA from your QbD and your cGMPs? You’re not alone! In our new Pharma Explained series from CPHI, we bring you clear cut definitions from industry experts on a myriad of Pharma Terms, delivered in bitesize video present... -
News BMS expands global footprint with new cell therapy manufacturing facility
The new site will be equipped to enable quick ramp-up of capacity for clinical and commercial cell therapy products -
News Pharma manufacturing going digital in bid for quality and efficiency
Digitalisation is finally coming to pharma with more drug manufacturers using industry 4.0 tech to monitor, model and control production processes. -
News Catalent secures softgels commercial supply agreement with Aurinia
The CDMO will manufacture recently FDA-approved Lupkynis as a softgel dosage form at its St Petersburg, Florida, facility -
News MaxiVAX and Minaris strike immunotherapy manufacturing partnership deal
The manufacturing agreement includes process development for scale-up and technology transfer with the goal of supplying Phase II and III clinical studies -
News Novavax agrees huge supply deal with Gavi for 1.1 billion doses of COVID-19 vaccine
Biotech will manufacture shots with partner SII for equitable vaccine distribution programme, COVAX -
News Wavelength takes majority stake in Vanamali to strengthen drug substance manufacturing
API manufacturer says acquisition is next step of investment strategy to closely align API supply to customer needs in an unpredictable world -
News The Top Five Product Searches on CPHI Online: January
Which were the products that drew the most interest in the CPHI directory in January? We analyse search data from the CPHI directory… -
News Cascade Chemistry starts $14 million API manufacturing expansion
CDMO says increased customer demand for clinical API supply has outstripped its cGMP manufacturing capacity -
News Pharma should track online vaccine conversations to gain consumer insights and fight misinformation, says Talkwalker study
Online analysis finds vaccine misinformation continues to thrive despite recent approvals and inoculation programmes -
News Regis completes expansion of US-based API development facility
The CDMO doubles its capacity to take on new development projects -
News CPHI Podcast Series: Pharma 4.0 and the Digitalisation of Manufacturing
In this episode we delve into the issue of Pharma 4.0 and what steps the industry is taking to transition pharma manufacturing to a much more digitalised model. -
News Lonza boosts solid form services for small molecule APIs
The expanded and refined first-in-human services have been designed to meet the early-stage molecule development of small biopharma players -
News Phlow secures $20 million to advance manufacturing initiatives in the US
The company seeks to actively accelerate US manufacturing for medicines at risk of shortage, including those for COVID-19 pandemic response -
News Dermapharm expands COVID-19 vaccine production capacity at ex-Merck site
The company's additional production capacities are scheduled to go into operation in May 2021 -
News AstraZeneca partners with IDT Biologika to build COVID-19 vaccine facility in Germany
Firms plan to invest in capacity expansion at the CDMO’s manufacturing site in Dessau to boost European domestic vaccine supply -
News Pharmapack Podcast Series: Patient-Centric Packaging Design & Innovation - Part One
Partnering with one of northern Europe’s oldest universities, Lund University in Sweden, Pharmapack is launching this three-part podcast series, delivering the latest insights on medication packaging innovation and the gathering momentum towards ... -
News Pharma Explained: What is Quality Risk Management & cGMPs?
Need clarity on determining your QA from your QbD and your cGMPs? You’re not alone! In our new Pharma Explained series from CPHI, we bring you clear cut definitions from industry experts on a myriad of Pharma Terms, delivered in bitesize video presenta... -
News Quotient Sciences expands service portfolio with Arcinova acquisition
The acquisition will extend the 12-month drug development timeline savings already delivered by Quotient’s flagship platform Translational Pharmaceutics -
News Catalent secures Trizell cell therapy development and manufacturing contract
The agreement allows the CDMO to "stay on the forefront of emerging indications and cell types" -
News Clinical knowledge deficits to slow biotech development, warns Europital
The CRO predicts investment communities will come to the rescue of small and medium companies looking to advance their candidates -
News Argonaut Manufacturing Services opens custom controls & standards facility
The CMO has designed the new service to alleviate manufacturing challenges associated with positive controls and nucleic acid templates -
News WuXi STA to grab foothold in Europe with planned BMS facility purchase
The acquisition will expand the CDMO's capabilities and capacity to serve European markets -
News Innovation in Drug Delivery - Part One: The trend towards self-administration
By Yifei Chen and Yasemin Bettina Karanis, IQVIA
-
News Innovation in Drug Delivery - Part Two: Therapy area trends for injectables
By Yifei Chen and Yasemin Bettina Karanis, IQVIA -
News Sepha launches small batch contract packaging service amid rising demand
The CPO's new division will offer a holistic blister packaging development service, complete with QA and non-destructive leak testing, encompassing material selection, tooling design, and 3D prototyping -
News Resyca joint venture ready to push the boundaries of softmist technology
Joint venture between Recipharm and Medspray could provide significant advantages for patients and the environment, companies say -
News COVID-19, cancer and competition: Key demand dynamics for the API sector
How are changes in new treatments and disease areas – as well as the current pandemic crisis - affecting demand for APIs? -
News Almac expands global biologics testing services with mass spectrometry investment
The company's £0.5 million investment in mass spectrometry support accelerates biologics development and approval -
News EU delivers export threat after AstraZeneca cuts Q1 vaccine supply
European Commission pressures pharma firm over reduced shipments amid criticism for slow vaccine rollout across block -
News Emergent to manufacture Humanigen COVID-19 therapeutic
The CDMO gears up for rapid deployment of its clinical-to-commercial manufacturing operations for its seventh collaboration to help deliver COVID-19 treatments -
News Thermo Fisher snaps up diagnostic specialist Mesa Biotech for $450 million
Acquisition will add Mesa's rapid PCR test for infectious diseases including COVID-19 to global CDMO's diagnostics offering -
News Oxford University to create institute to fight antimicrobial resistance after Ineos donation
The donation from Ineos will create a new institute to tackle the "silent pandemic" -
News CPHI Podcast Series: Digitalisation of API Supply Chains
Even before the COVID-19 pandemic, the pharmaceutical manufacturing sector was adopting digital technology to save time, cut costs and increase efficiencies in the value chain. -
News Top 5 Industry Content Reads on CPHI Online This Month
If you’re looking for news, product information and market trends from leading pharma companies, the CPHI-Online.com Company Showcases are a great resource for buyers who want to stay up to date, browse product portfolios and find the right partn... -
News Eight current drivers of the API production revolution
Manufacturing of active pharmaceutical ingredients has always been about innovating to cater for shifting demand patterns, but the recent coronavirus pandemic has raised further questions about whether the sector is doing enough to eke out efficiencies... -
News Sartorius and RoosterBio partner to advance scale-up of hMSC manufacturing
The collaboration aims to accelerate the development and commercialization of groundbreaking cell-based regenerative cures -
News Thermo Fisher buys Novasep viral vector manufacturing business
Expanded global capacity addresses growing demand for cell and gene therapy -
News Private health insurance uptake boosted by COVID-19 in MENA region, says latest Fitch report
New report from Fitch Solutions points to greater consumer awareness of health insurance benefits in MENA region amid pandemic crisis and assesses individual countries' progress in vaccine procurement and rollout -
News Merck KGaA expands its mRNA capabilities through AmpTec acquisition
AmpTec's differentiated PCR-based technology has shown to have advantages compared with other technologies for mRNA manufacturing -
News The Top Five Product Searches on CPHI Online: December
Which were the products that drew the most interest in the CPHI directory in December? We analyse search data from the CPHI directory… -
News Preparing for mass vaccination
Needle free systems offer compelling advantages for mass vaccination - could this be a potential platform for COVID19 vaccination programmes? -
News Pharmapack Podcast Episode 3: Wearable Drug Delivery Systems
Increasing complexity of novel drugs and cost constraints have encouraged medicines administration to be shifted away from their traditional setting of a hospital or clinic to more cost-effective alternatives such as the patient’s own home. The a... -
News Baxter BioPharma Solutions to manufacture Novavax COVID-19 vaccine
Manufacturing at Baxter's Halle/Westfalen, Germany facility will help increase commercial production and promote access in UK and European markets -
News Abzena to open new biologics GMP manufacturing site in the US
The new facility will house up to 12 X 2000-L bioreactors and will be equipped to handle existing and new advances in manufacturing -
News Bavarian Nordic to supply smallpox vaccines to three European countries
The company hopes its newly built fill and finish facility will assume commercial manufacturing this year -
News Fujifilm Diosynth Biotechnologies to establish new viral vector manufacturing facility in Boston
The $40 million investment marks the company's third viral vector manufacturing site -
News AGC Biologics becomes first manufacturer of newly approved Libmeldy
The CDMO will use its gene and cell therapy commercial expertise to bring "remarkable innovation" to young eligible patients -
News Wuxi agrees €150 million deal to buy Wuppertal drug substance facility from Bayer
Acquisition will extend the Chinese CDMO’s European footprint and will complement Leverkusen drug product site -
News Lonza to expand bioconjugation capabilities at Visp site
CDMO will add two production suites for clinical and commercial supply and extend lab space to double analytical and process development capacity -
News Calculating Scope 3 Greenhouse Gas Emissions
The third in a quarterly series of blog posts about responsible supply chain management from the PSCI Chair, Caroline O'Brien
-
News Viatris to slash up to 9,000 jobs at manufacturing facilities as part of global cost-cutting plan
Newly formed generics business identifies the first five impacted plants as it seeks to reduce costs by $1 billion by the end of 2024 -
News Spanish CDMO Reig Jofre to manufacture Janssen COVID-19 vaccine candidate
The company will be responsible for the formulation, filling, and packaging of Ad26.COV2-S at its new €30 million injectable products plant in Barcelona -
News Thermo Fisher boosts clinical supply chain and distribution services in Europe
Two new facilities in Germany will provide clinical supply and cold chain services to support growing demand -
News Lilly nabs gene therapy company Prevail Therapeutics
Through the acquisition, Lilly will establish a gene therapy program via Prevail's gain clinical-stage and preclinical neuroscience assets -
News As the pharma packaging world becomes more personalized, what does it mean?
With a value of more than $1,000 billion in 2019 and enjoying a 5% increase during that year, the global pharmaceutical sector is in good health. But it is also a moving universe, in which both the digital and design revolutions have changed the game o... -
News Vectura expands capabilities to develop highly potent inhaled drugs
The expansion will enable the CDMO to widen the nature of inhaled drug development projects it can undertake for customers -
News AstraZeneca taps Halix for commercial drug substance manufacture of COVID-19 vaccine
Dutch CDMO will expand with two additional viral vector production lines to meet the increased demand -
News Catalent starts manufacture of Passage Bio's lead gene therapy products
The CDMO will provide packaging, labeling and distribution services through its FastChain demand-led supply offering -
News BD unveils $1.2 billion investment in pre-fillable syringe manufacturing
World’s largest syringe maker gears up for increased demand across all product classes amid expected COVID-19 vaccine roll out -
News Sterling paves the way for ADC Bio acquisition with strategic partnership
UK-based CDMO makes ‘significant investment’ as companies combine HPAPI small molecule expertise with antibody drug conjugate specialism -
News Cancer, rare diseases and revenue eclipse COVID-19: The drug approval drivers in 2020
COVID-19 has been a major focus for drug regulators on both sides of the Atlantic in 2020. But efforts to help industry combat the pandemic did not appear to have had a major impact on review activities judging by the drugs approved so far this year -
News AGC Biologics to boost its biopharmaceutical CDMO capacity in Denmark
The €160 million investment will double the company's single-use bioreactor mammalian cell-culture capacity -
News FUJIFILM Irvine Scientific introduces Sterile Express Media Service
The first-of-its-kind manufacturing service delivers tested sterile, non-GMP media designed for feasibility testing before scale-up, to support development of cell and gene therapies -
News CSafe Global launches real-time shipment visibility platform
Industry customers now have access to 24/7 real-time shipment visibility across the company's entire product portfolio -
News Eyesight Health Ingredients Market Trends
The Eyesight Health Market is emerging and related products are a booming business. With age, aging and the overuse of electronics in work and life, especially in 2020, people are spending more time on smartphones, tablets and e-readers because of the ... -
News Live Webinar: Strengthening a sustainable API supply chain performance.
At Dr. Reddy’s, we’re in the business of ensuring good health for both people and the planet. Our experts will share insights on our sustainability approach and on how it helps B2B customers support their sustainable supply chain performance while sour... -
News Plastic coating and printing options for glass packaging
Discover all key features and benefits of plastic coating options offered by SGD Pharma -
News The Top 5 Industry Content Reads on CPHI Online
If you’re looking for news, product information and market trends from leading pharma companies, the CPHI-Online.com Company Showcases are a great resource for buyers who want to stay up to date, browse product portfolios and find the right partn... -
News The Top Five Product Searches on CPHI Online: November
Which were the products that drew the most interest in the CPHI directory in November? -
News Lonza expands development and manufacturing capabilities at Bend site
The company will invest in dedicated early-phase development and cGMP manufacturing to help customers rapidly advance challenging molecules -
News CPHI Online Report - Pharma Market Trends 2021
Twelve pharma market trends we anticipate across 2021 for the drug development, manufacturing and outsourcing sectors. -
News AZ and Oxford COVID-19 vaccine brings end of pandemic a little closer
AZD1222 is 90% effective, cheap to produce and easy to store, distribute and administer -
News Recipharm signs up for aseptic fill-finish manufacturing of Moderna COVID-19 vaccine
The CDMO is already making certain investments to enable technology transfer and scale-up to commence imminently. -
News Alvotech and Yangtze River forge biosimilar deal for Chinese market
The partnership will focus on commercializing eight biosimilar medicines in China for the domestic market -
News CPHI & P-MEC China 2020 adapts to customer needs with hybrid pharma event
Virtual Expo Connect to empower access for international pharma to the world’s largest pharma ingredients market -
News Catalent signs commercial supply agreement with Blueprint Medicines
The agreement comes hot on the heels of FDA approval of Gavreto — Blueprint Medicines' new treatment for lung cancer -
News A next generation, pilot-scale continuous sterilization system for fermentation media
Junker, B., Lester, M., Brix, T., Wong, D., & Nuechterlein, J. (2006). A next generation, pilot-scale continuous sterilization system for fermentation media. Bioprocess And Biosystems Engineering, 28(6),
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance